Efficacy and Safety of Curcumin in Major Depressive Disorder: A Randomized Controlled Trial-Reference-Cited by-同舟云学术

Efficacy and Safety of Curcumin in Major Depressive Disorder: A Randomized Controlled Trial

Author:

Sanmukhani Jayesh¹,Satodia Vimal²,Trivedi Jaladhi²,Patel Tejas¹,Tiwari Deepak²,Panchal Bharat²,Goel Ajay³⁴,Tripathi Chandra Bhanu¹

Affiliation:

1. Department of Pharmacology, Government Medical College, Bhavnagar; Gujarat India

2. Department of Psychiatry, Sir T General Hospital, and Government Medical College Bhavnagar; Gujarat India

3. Baylor Research Institute and Charles A Sammons Cancer Center; Baylor University Medical Center; Dallas TX USA

4. Gastrointestinal Cancer Research Laboratory; Baylor University Medical Center; Dallas TX USA

Publisher

Wiley

Subject

Pharmacology

Link

Reference29 articles.

1. American Psychiatric Association 1994 Diagnostic and statistical manual of mental health disorders (4th ed) Washington DC

3. Major depressive disorder is a risk factor for low bone mass, central obesity, and other medical conditions;Cizza;Dialogues Clin Neurosci,2011

Cited by 161 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献